No Widgets found in the Sidebar
Possible Rebound for CVS Health Stock on the Horizon

Yesterday, health insurance stocks experienced a decline due to lower than expected final Medicare Advantage (MA) payment rates. This news also had an impact on CVS Health Corp (NYSE:CVS) stock, which saw a 7.2% drop – the largest daily percentage loss since August. Despite a modest recovery today, with shares up 0.7% at $74.37, the recent pullback has brought CVS close to its 200-day moving average, a trendline that has historically been bullish.

Before yesterday’s drop, CVS had been on an upward trend, with only three daily losses since March 14. Overall the stock is down 5.7% since the beginning of the year. However, Schaeffer’s Senior Quantitative Analyst Rocky White notes that CVS has been within one standard deviation of its 200-day moving average before, which resulted in a 3% gain on average one month later. Additionally, the stock’s 14-day relative strength index (RSI) of 29.4 suggests that it is oversold and could see a short-term bounce. It is worth considering buying the dip for those who are looking for opportunities in this market.

By Samantha Jones

As a dedicated content writer at, I bring a unique blend of creativity and precision to my work. With a passion for storytelling and a keen eye for detail, I strive to craft engaging and informative articles that captivate our readers. From breaking news to thought-provoking features, I am committed to delivering content that resonates with our audience and keeps them coming back for more. Join me on this exciting journey as we explore the ever-evolving world of news and information together.

Leave a Reply